IP Verse

Synthon Bv opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Synthon Bv

Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jul 25, 2024
Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 10, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Dec 7, 2023
Patent Number:
EP3647783
Title:
Identifying Patient Response To S1P Receptor Modulator Administration
Applicant:
NOVARTIS AG
Opposition Date:
Sep 21, 2023
Patent Number:
EP3661503
Title:
Antifungal Agents With Enhanced Activity In Acidic Ph
Applicant:
SCYNEXIS, INC.
Opposition Date:
Jun 7, 2023
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
May 22, 2023
Patent Number:
EP3782611
Title:
Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof
Applicant:
CELGENE CORPORATION
Opposition Date:
Mar 31, 2023
Patent Number:
EP3247711
Title:
Novel Salts And Polymorphs Of Scy-078
Applicant:
SCYNEXIS, INC.
Opposition Date:
Dec 9, 2022
Patent Number:
EP3076972
Title:
Cancer Treatment With Combination Of Plinabulin And Taxane
Applicant:
BEYONDSPRING, INC.
Opposition Date:
Jul 6, 2022
Patent Number:
EP3725778
Title:
Formulations Of Enzalutamide
Applicant:
ASTELLAS PHARMA INC.
Opposition Date:
May 18, 2022

Latest patents of Synthon Bv opposed by its competitors

Patent:
EP3474865
Grant Date:
Mar 2, 2022
Title:
Process For Making Sugammadex
Oppositions:
2
Patent:
EP2945948
Grant Date:
Apr 29, 2020
Title:
Crystalline Form Ii Of Anagrelide Hydrochloride Monohydrate
Oppositions:
1
Patent:
EP3206666
Grant Date:
Dec 11, 2019
Title:
Liquid Pharmaceutical Composition Comprising Pemetrexed
Oppositions:
1
Patent:
EP2621889
Grant Date:
Jul 17, 2019
Title:
Process For Making Fingolimod Hydrochloride Crystals
Oppositions:
1
Patent:
EP2658840
Grant Date:
Jul 3, 2019
Title:
Process For Making Fingolimod Hydrochloride Crystals
Oppositions:
1

Competitors of Synthon Bv

NOVARTIS AG

ARAGON PHARMACEUTICALS, INC.

KELTIE LLP

Want to track Synthon Bv?

Feel free to send us a message here and we will get back to you